3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
2
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
9
Leukemia, Myeloid, Acute
9
Endometrial Neoplasms
8
Breast Neoplasms
7
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Colonic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Multiple Myeloma
4
Melanoma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Congenital Abnormalities
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Mouth Neoplasms
3
Lymphoma, Follicular
3
Leukemia
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Interventions
VGX-3100
4
Light Coagulation
3
Biopsy
3
Watchful Waiting
2
Observation
2
Laser Therapy
2
Imiquimod
2
Fluorouracil
2
Electroporation
2
Colposcopy
2
Cidofovir
2
Aminolevulinic Acid
2
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone
2
epigallocatechin gallate
1
calcipotriene
1
Solutions
1
Restraint, Physical
1
Red Light
1
Radiofrequency Ablation
1
Probiotics
1
Polymerase Chain Reaction
1
Mindfulness-Based Stress Reduction
1
Megestrol Acetate
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
Gene Expression Profiling
1
Gels
1
GPI0100
1
Folic Acid
1
Electroporation Therapies
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Squamous Intraepithelial Lesions
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled